Skip to main content
OpenTrials

Clinical trial condition

Hormone-refractory Prostate Adenocarcinoma, Ovarian Cancer

Explore clinical trials studying Hormone-refractory Prostate Adenocarcinoma, Ovarian Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Hormone-refractory Prostate Adenocarcinoma, Ovarian Cancer trial results

Completed

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

NCT01460134

Conditions
Adenocarcinoma, Adnexal Diseases, Any T-cell Malignancy, +70 more
Locations
  • Mayo Clinic Arizona - Cancer Clinical Research Unit Scottsdale, Arizona, United States
  • Stanford Cancer Center - Stanford University Stanford, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine New York, United States
View Trial Details

Related conditions